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ABSTRACT
Introduction To support general practitioners
(GPs) in providing early palliative care to patients
with cancer, chronic obstructive pulmonary
disease or heart failure, the RADboud university
medical centre indicators for PAlliative Care
needs tool (RADPAC) and a training programme
were developed to identify such patients and to
facilitate anticipatory palliative care planning. We
studied whether GPs, after 1 year of training,
identified more palliative patients, and provided
multidimensional and multidisciplinary care more
often than untrained GPs.
Methods We performed a survey 1 year after GPs
in the intervention group of an RCT were trained.
With the help of a questionnaire, all 134 GPs were
asked how many palliative patients they had
identified, and whether anticipatory care was
provided. We studied number of identified
palliative patients, expected lifetime, contact
frequency, whether multidimensional care was
provided and which other disciplines were involved.
Results Trained GPs identified more palliative
patients than did untrained GPs (median 3 vs 2; p
0.046) and more often provided multidimensional
palliative care (p 0.024). In both groups, most
identified patients had cancer.
Conclusions RADPAC sensitises GPs in the
identification of palliative patients. Trained GPs
more often provided multidimensional palliative
care. Further adaptation and evaluation of the tools
and training are necessary to improve early
palliative care for patients with organ failure.
Trial registration number NTR2815; post results.
INTRODUCTION
Many patients at an advanced stage of
cancer or other life-limiting disease suffer
from problems such as pain, nausea or
depressed mood.1–3 In several studies
from the USA and Canada, mainly
regarding patients with cancer, early pal-
liative care increased quality of life and
decreased emotional distress and useless
aggressive interventions.4–6 Despite these
positive findings, palliative care is still
often restricted to reactive terminal care
and to patients with cancer.7 However,
not only do existing problems and
requirements need to be addressed,
future scenarios should also be consid-
ered. Early initiation of palliative care
enables anticipation of future problems,
needs and wishes of patients.
Also, in the Netherlands, early palliative
care is not a part of daily practice. The GP
is the preferred professional to coordinate
palliative care8 as most patients live at
home in the final phase of their lives. Every
person has his or her own gate keeping GP;
also, out of hours care is arranged via the
GP out-of-hours cooperatives, which, in
addition, have a gate keeping function. GPs
consider palliative care as an attractive and
important aspect of their profession, even
though it is demanding and challenging.9 10
However, they consider timely identifica-
tion of patients who can benefit from
anticipatory palliative care challenging, par-
ticularly in patients with chronic obstruct-
ive pulmonary disease (COPD) or chronic
heart failure (CHF), as the course of these
disease trajectories is difficult to
predict.2 11–14
For these reasons we developed the
RADboud university medical centre
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indicators for PAlliative Care needs (RADPAC), to
support GPs in the early identification of those
patients with cancer, COPD or CHF, who might
profit from palliative care.15 16 RADPAC contains
indicators for GPs, used as triggers to identify a need
for palliative care in these patient groups. Besides, we
developed a specific training programme for GPs on
using RADPAC and on how to provide structured
anticipatory palliative care. The effect of this training
was subsequently evaluated in a randomised con-
trolled trial (RCT) in which over 130 GPs partici-
pated.17 We did not find a difference between the
patients with cancer, COPD or CHF who died in the
year after the start of the RCT in any of the groups of
trained and untrained GPs in contact with the
out-of-hours GP cooperative in the patients’ final
months of life, contacts with their own GP, hospitali-
sations or place of death. However, of those patients
of trained GPs, who died in the year after the training,
only one-third had been identified by their GPs as
being palliative patients. Those patients actually iden-
tified had had significantly more contact with their
GP (13 vs 7.48/month), had undergone less hospitali-
sations (14% vs 32%), and more often died at home
(67 vs 45%) and less often in hospital (14 vs 32%)
than all the other deceased patients.17 These retro-
spectively collected outcome measures of deceased
patients were limited to short-term effects, did not
provide insights into the palliative care provided, and
did not provide insights into the effects of the several
components of the training.
For those reasons, 1 year after start of the RCT, we
studied whether trained GPs at that time cared for a
larger number of palliative patients than the untrained
GPs, and whether the care provided was more often
multidimensional (exploration of somatic, social and
financial, caregiving and activities of daily living, and
existential and psychological problems and needs) and
multiprofessional (different types of healthcare profes-
sionals involved). Finally, in the untrained GP group,
we studied the short-term effect of providing the
RADPAC.
METHODS
Design
We performed a survey 1 year after the start of an
RCT, begun in 2010, to compare trained (interven-
tion) and untrained (control) GPs as additional, sec-
ondary outcomes.
Ethical procedures
The study was conducted after approval of the
research ethics committee of the Radboud University
Nijmegen Medical Centre in accordance with the
Medical Research Involving Human Subjects Acts
(WMO) (registration number 2007/205), and regis-
tered in the Netherlands Trial Register (NTR2815).
Participants
In total, 134 GPs who had participated in the RCT
1 year prior received a questionnaire by mail in Spring
2011. Of them, 57 GPs (intervention group) had been
trained 1 year prior in the early identification of their
palliative patients, using the RADPAC, and in provid-
ing structured proactive palliative care in their daily
practice, while the 77 untrained GPs had provided
care as usual (control group).
Intervention that the trained GPs had received 1 year prior
One year before this survey, those GPs allocated to
the intervention group had undergone a 5 h group
training session in early identification and proactive
palliative care planning. During this training, they
received and practised with the following tools, devel-
oped within our research group: (1) the RADPAC, a
tool with specific indicators to identify patients with,
respectively, COPD, CHF and cancer, who might
profit from palliative care,16 and (2) a proactive pallia-
tive care planning card, the ‘problems and needs
square’: a tool to make a structured proactive care
plan in which actual as well as possible future pro-
blems (somatic, social and financial, caregiving and
activities of daily living, and existential and psycho-
logical), dying scenarios and patient’s’ wishes and
needs are considered. The GPs of the trained group
were invited to apply this knowledge and these tools
in their daily practice, and thus to identify palliative
patients and to make a proactive palliative care plan
for each of them (see online supplementary appendi-
ces 1 and 2).
Regarding each identified palliative patient, the
trained GPs were offered an individual coaching
session by phone, with a consultant specialised in pal-
liative care. During this session, they discussed the
anticipatory care plan the GP had prepared, and
adapted it if needed. Finally, all trained GPs were
offered two additional face-to-face peer group ses-
sions in which experiences could be exchanged and
they could practise communicating end of life aspects
on simulated patients.16 The GPs in the control group
had received neither training nor intervention.
Data collection
Baseline characteristics, demographics and practice
characteristics of the GPs had been collected 1 year
prior, at the start of the RCT. These were age, gender,
fulltime equivalent work experience, years of experi-
ence as a GP (≤1 year, 1–5 years, 5–9 years,
≥10 years), their interest in palliative care (numeric
rating scale (NRS) from 0, no interest at all, to 10,
very interested) and their self-efficacy in providing
palliative care (NRS from 0, no confidence at all, to
10, very confident). Also collected was information
on the kind of practice (solo, duo or group) and the
degree of urbanisation of their general practice as well
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as their mean patient list and the estimated number of
palliative patients per year.
Effects on the provision of palliative care, 1 year after the
training took place
With the help of a questionnaire, all GPs (trained or
untrained) were asked how many palliative patients
they currently cared for. They did not receive a defin-
ition of palliative care, but they did know that the
research project concerned identification of and pro-
active care planning for palliative patients with the GP
as coordinator. Of each of these patients, they were
asked to provide gender, age, disease (cancer, COPD,
CHF, other), expected remaining lifetime (in weeks),
their current type and number of contacts with the
patient (per month; respectively, by phone, consult-
ation or home visits); whether a key information
summary had been handed over to the GP out-of-hours
cooperative; which type of problems they had explored
(somatic, social and financial, care giving and activities
of daily living, spiritual and psychological aspects; yes/
no questions) and the type of other involved disciplines
in the care for the patient (physiotherapist, spiritual
caregiver, social worker, medical specialist, palliative
care consultant, psychologist, nursing aid at home,
volunteers; yes/no questions).
Short-term effects of applying RADPAC
Three weeks after having received the questionnaire,
GPs in the control group who had responded to the
first questionnaire were sent the RADPAC, which they
had never seen before.16 They were asked to complete
another, similar questionnaire again, in which they
could add those palliative patients they recognised as
being palliative, after being triggered by the RADPAC
indicators.
Statistical analysis
To study differences between trained and untrained
GPs, we analysed, using the data of the first question-
naire, the number of palliative patients the GPs were
currently aware of and their characteristics, as well as
the estimated remaining lifetime (mean and %
>4 weeks)—whether or not the GP out-of-hours
cooperative was informed—the number and type of
palliative care domains that were considered per
patient as well as the percentage of patients who had
had a multidimensional problem and needs explor-
ation (operationalised as three or more domains being
explored) and number and type of involved disci-
plines. Additional palliative patient data collected
from the untrained GPs after having received the
RADPAC were not included in these analyses but
described separately.
Statistical analyses were performed with the use of
SPSS software, V.20.0. Descriptive statistics were used
to calculate frequencies, means and SDs of the study
variables. Differences between trained and untrained
GPs, and between patients of trained and of untrained
GPs, were assessed with the use of Fisher Exact tests
for categorical variables, as some cells counted less
than 5 and, because of the relatively small number of
patients, with the non-parametric Mann Whitney tests
for continuous variables. As these data concerned sec-
ondary outcomes of an RCT, no power calculation
was made.
RESULTS
In total, 12/57 trained GPs (21%) from the interven-
tion group and 28/77 (36%) of the control group
filled in the questionnaire. Responding trained and
untrained GPs had about the same mean age (45 and
48 years, respectively; table 1). Of the trained GPs,
75% were males, and of the untrained GPs, 68% were
males. Besides, 42% of the trained GPs and 63% of
the untrained GPs worked fulltime. A lower percent-
age of the trained GPs had 10 or more years’ experi-
ence (67 vs 78%). Their interest in palliative care was
the same (both NRS 8) as well as their self-efficacy in
providing it (both NRS 7). Most trained GPs worked
in a dual practice (58%), and the untrained GPs more
often in a solo (32%) or group practice or healthcare
centre (39%). Of the trained GPs, 67% worked in an
urban region, while this figure was 50% for the
untrained GPs. The patient list of the practice where
the trained GPs worked was higher than the list of the
practices of the untrained GPs (respectively, 3491 and
2787 patients). Almost all GPs in both groups were
estimated to have between 0 and 5 palliative patients
per year (75% and 86%, respectively).
Of the non-responders, the percentage of women
was higher, they worked in larger practices with a
longer patient list and with more palliative patients
(table 1).
In total, all GPs together had identified 119 (46
plus 73) palliative patients (figure 1). The trained GPs
had identified a median of 3 palliative patients, which
was significantly higher than the median of 2 patients
in the untrained group (p 0.046; table 2).
Of the palliative patients, the median age was about
the same in both groups (74.5 vs 70 years; p 0.064) as
well as their gender (44% vs 55% males; p 0.544). In
both groups, the primary diagnosis was most often
cancer (76% and 80%; p 0.630). The category ‘other’
diseases (respectively, 20% and 19%) mostly con-
cerned a combination of either cancer and CHF, CHF
and COPD, or COPD and cancer. A few times, other
diagnoses such as dementia, amyotrophic lateral scler-
osis, a cerebrovascular accident or chronic kidney
failure were mentioned.
The median estimated remaining lifetime of the pal-
liative patients was about the same in trained and
untrained GPs (16 vs 20 weeks; p 0.728). The percent-
age of expected remaining lifetime being ≥4 weeks was
non-significantly higher in patients of the trained GPs
(94% vs 64% of the patients; p 0.062).
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Table 1 General practitioners and practice characteristics responders and non responders
GPs participating in the RCT 1 year prior
Intervention (n=12)
Control (n=28)
Intervention (n=45)
Control (n=49)Responders Non-responders
Age in years mean (SD) 45 (8) 48 (8) 49 (8) 48 (8)
Male gender n (%) 9 (75.0) 19 (67.9) 27 (60.0) 26 (53.1)
Working hours n (%)
Fulltime 5 (41.7) 17 (63.0) 21 (46.7) 25 (51.0)
Part-time 7 (58.3) 10 (37.0) 24 (53.3) 24 (49.0)
Years of experience n (%)
≤1 0 (0) 0 (0) 1 (2.3) 1 (2.0)
1–5 2 (16.7) 2 (7.4) 3 (6.8) 7 (14.3)
6–10 2 (17.7) 4 (14.8) 9 (20.5) 6 (12.2)
≥10 8 (66.7) 21 (77.8) 31 (70.5) 35 (71.4)
Interest in pall care*
NRS 0–10 (IQR)
8.0 (0.0) 8.0 (1.0) 8.0 (1.0) 8.0 (2.0)
Estimation of self-efficacy in palliative care provision†
NRS 0–10 (IQR)
7.0 (2.0) 7.0 (0.5) 7.0 (0.8) 7.0 (1.0)
Practice type n (%)
Single-handed 2 (16.7) 9 (32.1) 7 (15.6) 10 (20.4)
Dual 7 (58.3) 8 (28.6) 21 (46.7) 18 (36.7)
Group or health centre 3 (25.0) 11 (39.3) 17 (37.8) 21 (42.9)
Urbanisation degree n (%)
Urban 8 (66.7) 14 (50) 22 (48.9) 32 (65.3)
Rural 4 (33.3) 14 (50) 23 (51.1) 17 (34.7)
Patient list mean (SD) 3491 (1579) 2787 (1389) 3602 (2101) 3024 (1535)
Estimated number of palliative patients/year n (%)
≤2 4 (33.3) 13 (46.4) 3 (3.8) 6 (12.2)
3–5 5 (41.7) 11 (39.3) 22 (50.0) 24 (49.0)
6–9 3 (25) 3 (10.7) 16 (36.4) 16 (32.7)
≥10 0 (0) 1 (3.6) 3 (6.8) 3 (6.1)
*Interest in palliative care: numeric rating scale (NRS) from 0 (no interest at all) to 10 (extremely interested).
†Estimation of self-efficacy: NRS from 0 (not capable at all) to 10 (extremely capable).
GPs, general practitioners; RCT, randomised controlled trial.
Figure 1 Prisma flow chart of involved GPs and identified palliative patients. GP, general practitioner; RCT, randomised controlled
trial; RADPAC, RADboud university medical centre indicators for PAlliative Care needs.
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We found no significant difference between trained
and untrained GPs in the percentage of patients of
whom the GP out-of-hours cooperative was informed
(57% vs 62%; p 0.324).
The median number of total contacts with their
own GP was about the same in both groups (4 vs 2;
p 0.690). Almost all patients had had at least one
monthly contact with their GP. The percentage of
patients who had had at least one contact by phone
was higher in the trained GP group (52% vs 28%;
p 0.025). The percentage of patients who had had at
least one monthly consultation did not differ signifi-
cantly between either group (28% vs 18%; p 0.243),
nor did the percentage of patients with at least one
home visit per month (80% and 86%; p 0.739).
The median number of explored dimensions
(somatic, social and financial, activities of daily living
(ADL), and spiritual and psychological) did not differ
Table 2 Characteristics of identified palliative patients and palliative care they received
Patients of trained GPs (n=46) Patients of untrained GPs (n=73) P Value
Number of identified patients median (min-max) 3 (2–8) 2 (1–7) 0.046
Age in years median (min-max) 74.5 (39–96) 70 (10–98) 0.064
Male gender* n (%) 20 (43.5) 35 (54.7) 0.544
Missing 5 9
Primary diagnosis* n (%) 0.630
Cancer 34 (75.6) 58 (79.5)
COPD 2 (4.4) 1 (1.4)
CHF 0 (0) 0 (0)
Other† 9 (20) 14 (19.2)
Expected lifetime weeks median (min-max) 16 (2–100) 20 (1–82) 0.728
Expected remaining lifetime ≥4 weeks* n (%) 43 (93.5) 47 (64.4) 0.062
Missing<s> expected life time n (%) 3 (7) 14 (19)
Current monthly contact frequency median (min-max) 4 (0–24) 2 (1–36) 0.690
Contact(s) per patient with own
GP last month ≥1 monthly n (%)
By phone office hours 25 (52.1) 19 (27.5) 0.025
By consultation office hours 14 (27.5) 12 (17.6) 0.243
Home visits office hours 41 (80.4) 60 (85.7) 0.739
GP informed out-of-hour service about patient* n (%) 26 (56.5) 45 (61.6) 0.324
Type of dimensions* n (%)
Somatic 25 (54.3) 39 (53.4) 0.852
Social and financial 7 (15.2) 7 (9.6) 0.564
Activities of daily living (ADL) 24 (52.2) 30 (41.1) 0.455
Spiritual and psychological 19 (41.3) 17 (23.3) 0.103
Number of dimensions median (minimum–maximum) 2 (0–4) 1 (0–4) 0.266
Number of dimensions* n (%)
0 dimensions 20 (43.5) 31 (42.5)
1 dimension 1 (0.02) 7 (0.1)
2 dimensions 5 (0.3) 20 (43.5)
≥3 dimensions 20 (43.5) 15 (20.5) 0.024
Type of disciplines* yes (%)
Physiotherapist 1 (2) 7 (10) 0.141
Spiritual caregiver 2 (4) 5 (7) 0.700
Social work 0 (0) 2 (3) 0.515
Medical specialist 34 (74) 49 (67) 0.416
Palliative care consultant 3 (7) 7 (10) 0.738
Psychologist 0 (0) 2 (3) 0.515
Home care (nurse) 19 (41) 21 (29) 0.323
Volunteers 2 (4) 12 (16) 0.043
Number of disciplines median (min-max) 2 (0–4) 2 (0–5) 0.849
*=Fisher exact for categorical variables. Other p values are Mann Whitney tests.
†Combination of CHF, COPD and cancer or another disease such as dementia, neurological causes or kidney failure. Data are mean (SD) or n (%). Some
percentages do not sum to 100% because of rounding.
CHF, chronic heart failure; COPD, chronic obstructive pulmonary disease; GP, general practitioner.
Bold indicates statistically significant p-values.
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significantly (2 and 1, respectively; p 0.266), but
trained GPs more often explored ≥3 dimensions
(44% vs 21%; p 0.024). In the patients of the trained
GPs, the spiritual and psychological dimension was
twice as often explored, but this difference was not
significant (41% vs 23%; p 0.103).
The median number of other involved disciplines was
the same in both groups (2; p 0.849). In the care of
patients of the untrained GPs, volunteers were signifi-
cantly more often involved (4% and 16%; p 0.043).
Three weeks after the first questionnaire, the
untrained GPs who had responded to the first ques-
tionnaire received the RADPAC, and were asked to
use it and to then complete a similar questionnaire
again, adding patients additionally identified as
being palliative. Six untrained GPs (6/28=21% of the
GPs who responded to the first questionnaire) also
completed this questionnaire and became aware of a
mean of 3 additional palliative patients (table 3).
These six GPs had already identified a mean of 1.8
patients after the first questionnaire. Of these 18
patients, 5 patients (28%) had chronic organ failure.
DISCUSSION
One year after start of an RCT in which GPs in the
intervention group were trained in identifying their
palliative patients and in structured, proactive pallia-
tive care, trained GPs were aware of significantly
more palliative patients in their practice and more
often provided multidimensional care. With the help
of an additional questionnaire a few weeks later, we
also found that untrained GPs who received the
RADPAC identified additional palliative patients.16
The percentage of patients with an expected remain-
ing lifetime of ≥4 weeks was non-significantly higher
in the trained GP group. However, as we performed a
cross-sectional study and did not follow-up when these
patients actually died, we do not know how long the
actual survival was for and whether the correctness of
the estimation differed between trained and untrained
GPs. Twenty per cent of the untrained GPs did not
complete the question about the remaining lifetime
expectancy, while this figure was only 7% in the
trained GPs. In the untrained GPs, a prognostic paraly-
sis might have contributed to this large number of
missings.18 Two other studies also showed that it is
hard for GPs to provide such figures.9 19–23
Of the trained GPs, twice as many palliative patients
had had multidimensional problems and needs assess-
ment, meaning that at least three dimensions (somatic,
social and financial, ADL, and spiritual and psycho-
logical) were explored. Particularly, exploration of the
spiritual and psychological dimension contributed to
this difference. A Dutch study of Van der Brandt
showed that psychological and spiritual aspects of care
need more attention in the last days of dying
patients.24–26 Although person-centred, integrated
care belongs to the core values of GPs and the import-
ance of the biopsychosocial model in the chronic care
context has been recognised by all relevant Dutch sta-
keholders, this ideal appeared to be poorly embed-
ded8; our results suggest that this is also true for
palliative care. This is not a surprise, since guidelines
and standards as well as reimbursement of care expen-
ditures are mainly based on biomedical outcome indi-
cators, ignoring the psychological or spiritual aspects.
Most often, the somatic domain was explored by both
the trained as well as the untrained GPs. This finding is
in line with their medical background. However, in con-
trast to a study by Meijler et al,10 which showed that a
workshop in palliative care mainly improved attention
and knowledge of the somatic dimension, the trained
GPs in our study did not differ from the untrained GPs
in this aspect.27 As the somatic domain was only
explored in half of the identified patients, this also
implies that for half of the patients this was not carried
out, although it is known that many patients at an
advanced stage of cancer,1 COPD2 or CHF, suffer mul-
tiple problems and many patients do not report these
problems spontaneously.28 29
No significant difference between trained and
untrained GPs was found in the number of disciplines
involved in the palliative care of their patients. In
about two-third of the patients of the trained as well
Table 3 Untrained GPs who completed 1st and 2nd* questionnaires
Untrained GP (n=6) id
identified† palliative
patients 1st
questionnaire (n) Cancer
Identified‡ palliative
patients 2nd*
questionnaire (n) Cancer COPD CHF
Total (n) of identified
patients
A 1 1 1 1 2
B 1 1 2 1 1 3
C 1 1 2 1 1 3
D 4 4 6 5 1 10
E 3 3 3 3 6
F 1 1 4 2 1 1 5
*In this similar questionnaire, they were asked to mention additionally identified patients, triggered by the RADPAC that they had received alongside.
†These GPs only identified those patients with cancer who were mentioned in the first questionnaire.
‡No patients with diseases other than cancer, COPD or CHF were identified by these GPs.
CHF, chronic heart failure; COPD, chronic obstructive pulmonary disease; GP, general practitioner.
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as untrained GPs, a medical specialist was involved. In
many cases, palliative patients continue to visit the
medical specialist, even when no life prolonging treat-
ment options are available anymore. Weeks et al30
found that many patients with incurable cancer receiv-
ing chemotherapy did not understand that chemother-
apy is unlikely to be curative. This wrong perception
compromises their ability to make informed treatment
decisions. It implies that patients often receive treat-
ments for too long. Improving interdisciplinary col-
laboration between the medical specialist and GP
might contribute to shared decision-making regarding
advantages and disadvantages of treatment options.
The six untrained GPs who responded to the
second questionnaire, after having received the
RADPAC, became aware of a mean of 3 additional
palliative patients, which was even more than the 1.8
patients they mentioned in the first questionnaire, sug-
gesting that RADPAC contributes to the identification
of palliative patients. A quarter of these additional pal-
liative patients had COPD or CHF, which is a higher
percentage than in the first questionnaire of the
trained as well as untrained GPs, and more in line
with Dutch mortality data of these diseases.31
These positive effects indicate that RADPAC might
be an answer to the need for tools to identify pallia-
tive patients at an earlier stage.16 32–34
Strengths and weaknesses
This is one of the first studies that, using an additional
question within an RCT, evaluated long-term effects of
training in which GPs in the intervention group had
been trained in identifying patients in need of palliative
care and in providing structured, proactive palliative
care.15 16 In this study, we also tried to make a distinc-
tion between the effects of the RADPAC and those of
training in providing multidimensional palliative care.
Unfortunately, the response rate was extremely low.
Regarding the trained GPs, the response rate was only
21%. Of the untrained GPs, the response rate was
36%, but regarding the second questionnaire in this
group, this figure was also low (21%). Probably
mainly the most motivated GPs will have responded,
which might have influenced the results. Another
questionnaire regarding the primary and secondary
outcomes of the RCT, sent to the same GPs at the
same time and described elsewhere,17 resulted in a
response rate of 57%, which is much higher. An
explanation might be that the practice assistant could
complete that questionnaire, which concerned
deceased patients, while the questionnaire about
current palliative patients had to be completed neces-
sarily by the GP. The trained GPs had completed a
considerable number of forms during the intervention
period, the year before. Voting with their feet as a
result of fatigue regarding being asked again to com-
plete a questionnaire, and time investment of all GPs,
might have been barriers to completing it.35 The GPs
received this questionnaire in the run-up to a national
protest action, in which most Dutch GPs signed a
manifest, ‘Het roer moet om’ (A change of direction)
against the growing workload of administration,
forms and obligations.36 This probably will have con-
tributed to the low response rate. Another limitation
is that we had not asked how many palliative patients
the GPs cared for at baseline. Owing to this, the low
response rate and the fact that these data were second-
ary outcomes that were not used in a power calcula-
tion, all findings should be interpreted with caution.
CONCLUSIONS
This study shows that a training programme in pro-
active palliative care provision and in using RADPAC
to identify palliative patients even 1 year later
improves the number of identified palliative patients.
Additionally, multidimensional care, which could, par-
ticularly, be contributed to more attention given to
the spiritual and psychological dimension, was more
often offered by trained GPs.
Untrained GPs who 3 weeks after the first question-
naire received the RADPAC and were asked to consider
their patient list again to identify additional palliative
patients, in total identified more patients than the trained
GPs; and identified a larger percentage of patients with
COPD or CHF. This indicates that, although a training
programme in using the RADPAC still positively influ-
ences awareness of palliative patients 1 year later,
RADPAC seems to have the largest effect immediately
after applying it, and particularly in detecting patients
with COPD or CHF in need of palliative care. As
RADPAC is restricted to cancer, COPD and CHF, we rec-
ommend extension with indicators for other life-limiting
diseases, as has been carried out with other tools.20
Finally, we recommend an implementation trajec-
tory in which GPs as well as medical specialists are
involved, in which timely identification of palliative
patients is an ongoing process.
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